 0 Table of Contents |
  1 IDEA4RC FHIR IG - Home Page |
  2 IDEA4RC Model Overview |
  3 IDEA4RC Detailed ERD Model |
  4 IDEA4RC Logical Models |
  5 Useful Downloads |
  6 Condition-secondaryCancer-eu-i4rc Relationships |
  7 Encounter-eu-i4rc Relationships |
  8 Condition-primaryCancer-eu-i4rc Relationships |
  9 sarcoma-cancer-stage-group Relationships |
  10 hn-cancer-stage-group Relationships |
  11 episodeOfCare-eu-i4rc Relationships |
  12 MedicationAdministration-eu-i4rc Relationships |
  13 Subject Relationships |
  14 PatientFollowUp Relationships |
  15 EpisodeEvent Relationships |
  16 OtherTreatment Relationships |
  17 HospitalPatientRecords Relationships |
  18 HnStage Relationships |
  19 CancerEpisode Relationships |
  20 AdverseEvent Relationships |
  21 GeneticTestExpression Relationships |
  22 SarcomaStage Relationships |
  23 Surgery Relationships |
  24 Radiotherapy Relationships |
  25 Artifacts Summary |
   25.1 Adverse Event |
   25.2 Cancer Episode |
   25.3 Episode Event |
   25.4 Genetic Test Expression |
   25.5 Head and Neck Stage |
   25.6 Hospital Patient Records |
   25.7 Other Local Treatment |
   25.8 Pathological Report Info |
   25.9 Patient |
   25.10 Patient Follow-Up |
   25.11 Radiotherapy |
   25.12 Sarcoma Stage |
   25.13 Surgery |
   25.14 Systemic Treatment |
   25.15 Treatment Response |
   25.16 Cancer Episode Model to this guide Map |
   25.17 Episode Event Model to this guide Map |
   25.18 Genetic Test Expression Model to this guide Map |
   25.19 Genetic Test to this guide Map |
   25.20 Head and Neck Stage Model to this guide Map |
   25.21 Hospital Patient Records Model to this guide Map |
   25.22 Patient (Subject) Model to this guide Map |
   25.23 Patient Follow up Model to this guide Map |
   25.24 Radiotherapy Model to this guide Map |
   25.25 Sarcoma Stage Model to this guide Map |
   25.26 Surgery Model to this guide Map |
   25.27 Observation: Alcohol use |
   25.28 Observation: Cancer Treatment |
   25.29 Observation: Charlson Comorbidity Index |
   25.30 Observation: Comorbidities |
   25.31 Observation: ECOG Performance Status |
   25.32 Observation: Karnofsky Performance Status |
   25.33 Observation: Occurrence of the other cancer |
   25.34 Observation: Tobacco use |
   25.35 Patient: IDEA4RC |
   25.36 Condition: Metastatic Cancer |
   25.37 Condition: Primary Cancer |
   25.38 Observation: Diagnosis details |
   25.39 Observation: Head Neck Cancer Stage Group |
   25.40 Observation: Localized Category (Stage, Sarcoma) |
   25.41 Observation: LocoRegional Category (Stage, Sarcoma) |
   25.42 Observation: Radiological Extra-nodal extension (rENE) |
   25.43 Observation: Sarcoma Cancer Stage Group |
   25.44 Observation: TNM Distant Metastases Category |
   25.45 Observation: TNM Primary Tumor Category |
   25.46 Observation: TNM Regional Nodes Category |
   25.47 Encounter: IDEA4RC |
   25.48 Observation: date of the last contact |
   25.49 Observation: Status at the Last Follow Up |
   25.50 Procedure: Surgery |
   25.51 Procedure: Radiotherapy |
   25.52 MedicationAdministration: Chemotherapy |
   25.53 EpisodeOfCare: IDEA4RC |
   25.54 AdverseEvent: IDEA4RC |
   25.55 Bundle: IDEA4RC |
   25.56 Observation: test results |
   25.57 Observation: Yes / No assertions |
   25.58 Procedure: Other Treatment |
   25.59 Body Location Qualifier |
   25.60 Condition related to resource |
   25.61 Laterality Qualifier |
   25.62 Performed Timing |
   25.63 Previous Status |
   25.64 Race Extension |
   25.65 Radiotherapy Dose Delivered To Volume Extension |
   25.66 Radiotherapy Energy or Isotope |
   25.67 Radiotherapy Modality And Technique Extension |
   25.68 Radiotherapy Modality Extension |
   25.69 Radiotherapy Number of Sessions Extension |
   25.70 Radiotherapy Technique Extension |
   25.71 Relapse Type |
   25.72 Same custodian flag |
   25.73 Affected Organs (surgery) |
   25.74 Alcohol Usage Status: Athena |
   25.75 Alcohol Usage Status: SNOMED CT |
   25.76 Antineoplastic and immunostimulating agents |
   25.77 Beam Quality |
   25.78 Body site qualifier |
   25.79 Calculated|Estimated |
   25.80 Cancer Chondro Osseous Tumours: Athena |
   25.81 Cancer diagnosis: Athena |
   25.82 Cancer Endometrial stromal and related Tumors: Athena |
   25.83 Cancer Event Type: Athena |
   25.84 Cancer Histology Adenocarcinoma: Athena |
   25.85 Cancer Histology Neuroendocrine: Athena |
   25.86 Cancer Histology Odontogenic Carcinoma: Athena |
   25.87 Cancer Histology SNUC: Athena |
   25.88 Cancer Histology Squamous: Athena |
   25.89 Cancer Histology Subgroup Adipocytic Tumours: Athena |
   25.90 Cancer Histology Subgroup Fmt Tumours: Athena |
   25.91 Cancer Histology Subgroup So called Fibrohistiocytic Tumours: Athena |
   25.92 Cancer Miscellanious mesenchimal tumors: Athena |
   25.93 Cancer Mixed epithelial and mesenchymal tumours: Athena |
   25.94 Cancer Pericytic Perivascular Tumours: Athena |
   25.95 Cancer Peripheral Nerve Sheath Tumors: Athena |
   25.96 Cancer Skeletal Muscle Tumours: Athena |
   25.97 Cancer Smooth Muscle Tumours: Athena |
   25.98 Cancer Stage Grading: Athena |
   25.99 Cancer Stage Group Value: Athena |
   25.100 Cancer Stage Group: Athena |
   25.101 Cancer Tumors Of Uncertain Differentiation: Athena |
   25.102 Cancer undif. small round cell sarcomas of bone and soft tissue: Athena |
   25.103 Cancer Vascular Tumours: Athena |
   25.104 Chemotherapy cumulative dose units |
   25.105 Comorbidities: Athena |
   25.106 Comorbidities: SNOMED |
   25.107 Country: athena |
   25.108 Current Smoking Status: Athena |
   25.109 ECOG Performance Status |
   25.110 Event Type |
   25.111 Extranodal Extension |
   25.112 Gender: Athena |
   25.113 Genetic Tests performed (Yes/no/Unk) |
   25.114 Genito urinary subsite: Athena |
   25.115 Hypopharynx subsite: Athena |
   25.116 Hypopharynx subsite: Snomed CT |
   25.117 Intra abdominal subsite: Athena |
   25.118 Intra thoracic subsite : Athena |
   25.119 Larynx subsite: Athena |
   25.120 Larynx subsite: Snomed CT |
   25.121 Lip subsite: Athena |
   25.122 Lip subsite: Snomed CT |
   25.123 Margins After Surgery |
   25.124 Metastatis: Athena |
   25.125 Nasal cavity and paranasal sinuses subsite: Athena |
   25.126 Nasal cavity and paranasal sinuses subsite: Snomed CT |
   25.127 Nasopharynx subsite: Athena |
   25.128 Nasopharynx subsite: Snomed CT |
   25.129 Not Performed|Unknown |
   25.130 Observation Codes for Distant Metastases Category |
   25.131 Observation Codes for Primary Tumor Category |
   25.132 Observation Codes for Regional Node Category |
   25.133 Occurrence of other cancer |
   25.134 Oral cavity subsite: Athena |
   25.135 Oral cavity subsite: Snomed CT |
   25.136 Oropharynx subsite: Athena |
   25.137 Oropharynx subsite: Snomed CT |
   25.138 Pathological M |
   25.139 Pathological N |
   25.140 Pathological T |
   25.141 Positive-Negative-No Test: Athena |
   25.142 Race |
   25.143 Radiotherapy Device Type |
   25.144 Reason For End Of Treatment |
   25.145 Sarcoma Staging: localized disease |
   25.146 Sarcoma Staging: loco-regional category |
   25.147 Setting Radiotherapy |
   25.148 Simple measures |
   25.149 Site of metastasis |
   25.150 Site rare (IDEA4RC) |
   25.151 Smoking Status: LOINC |
   25.152 Status at the Last Follow Up |
   25.153 Subsites: Athena |
   25.154 Subsites: SNOMED CT |
   25.155 Surgery Complication |
   25.156 Surgery Intention |
   25.157 Surgery Outcome |
   25.158 Surgical Complications |
   25.159 Surgical Procedure Category |
   25.160 Surgical Procedure Type |
   25.161 TNM Distant Metastases Category Value Set |
   25.162 TNM Primary Tumor Category Value Set |
   25.163 TNM Regional Nodes Category Value Set |
   25.164 Tobacco Product |
   25.165 Treatment completed as planned |
   25.166 Treatment Response |
   25.167 Treatment Setting |
   25.168 Treatment Technique |
   25.169 Trunk wall subsite: Athena |
   25.170 Type of Biopsy |
   25.171 Type of Diagnosis |
   25.172 Type of surgical approach |
   25.173 Type of Systemic Treatment |
   25.174 Type of Treatment |
   25.175 Types of Yes/No observations |
   25.176 Upper and Lower limbs subsite: Athena |
   25.177 Yes-No-Unk: Athena |
   25.178 IDEA4RC Code System |
   25.179 Other Treatment to this guide Map |
   25.180 Radiotherapy Model to this guide Map |
   25.181 Actor: Head and Neck |
   25.182 Actor: Sarcoma |
   25.183 Condition: Grade 2 tumor with several body sites and evidences |
   25.184 Condition: Metastasis bone and pleura |
   25.185 Condition: NOT CLEAR WHAT IT REPRESENTS..TO BE DISCUSSED |
   25.186 Condition: Stable Disease |
   25.187 encounter-id-14 |
   25.188 EpisodeOfCare |
   25.189 GOFSH-GENERATED-id-28 |
   25.190 GOFSH-GENERATED-id-30 |
   25.191 GOFSH-GENERATED-id-36 |
   25.192 Observation: Alcohol use |
   25.193 Observation: BMI |
   25.194 Observation: C reactive protein Positive |
   25.195 Observation: Charlson Comorbidity Index |
   25.196 Observation: comorbidity |
   25.197 Observation: date of the last contact |
   25.198 Observation: Diagnosis |
   25.199 Observation: Dimension of Tumor |
   25.200 Observation: Distant metastases clinical M1 |
   25.201 Observation: Distant metastases pathology M1 |
   25.202 Observation: ECOG Performance Status score |
   25.203 Observation: Epstein Barr virus DNA Negative |
   25.204 Observation: gene Mutation Analysis Performed yes |
   25.205 Observation: Human papilloma virus Negative |
   25.206 Observation: immunohiostochemestry analysis performed |
   25.207 Observation: Karnofsky Performance Status score |
   25.208 Observation: Number of mitoses per HPF |
   25.209 Observation: Occurrence of other Cancer: Hamartoma |
   25.210 Observation: Primary tumor clinical T0 |
   25.211 Observation: Primary tumor pathological T0 |
   25.212 Observation: Radiological Extra-nodal extension |
   25.213 Observation: Regional lymph nodes Clinical N1 |
   25.214 Observation: Regional lymph nodes pathology N3b |
   25.215 Observation: Surgery treatment occurred |
   25.216 Observation: TNM clinical stage grouping |
   25.217 Observation: TNM pathology stage grouping |
   25.218 Observation: Tobacco use panel |
   25.219 Patient: race extension |
   25.220 Procedure: Isolated limb perfusion |